Open access
61 Salminen S, Collado MC, Endo A, et al . The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol 2021;18:649–67. 62 Cammarota G, Ianiro G, Kelly CR, et al . International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut 2019;68:2111–21. 63 Kragsnaes MS, Nilsson AC, Kjeldsen J, et al . How do I establish a stool bank for fecal microbiota transplantation within the blood- and tissue transplant service? Transfusion 2020;60:1135–41. 64 Cordaillat-Simmons M, Rouanet A, Pot B. Live biotherapeutic products: the importance of a defined regulatory framework. Exp Mol Med 2020;52:1397–406. 65 Gibson GR, Hutkins R, Sanders ME, et al . Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 2017;14:491–502. 66 Linde K, Clausius N, Ramirez G, et al . Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo- controlled trials. Lancet 1997;350:834–43. 67 Page MJ, Sterne JAC, Boutron I, et al . ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis. BMJ 2023;383:e076754. 68 Ghogomu EAT, Maxwell LJ, Buchbinder R, et al . Updated method guidelines for cochrane musculoskeletal group systematic reviews and metaanalyses. J Rheumatol 2014;41:194–205. 69 Klokker L, Tugwell P, Furst DE, et al . Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group. J Rheumatol 2017;44:1916–9. 70 Tugwell P, Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee. J Rheumatol 1993;20:555–6. 71 Maxwell LJ, Jones C, Bingham CO, et al . Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets. Semin Arthritis Rheum 2024;66:152423. 72 Maxwell LJ, Wells GA, Simon LS, et al . Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda. J Rheumatol 2015;42:1934–42. 73 Cauli A, Gladman DD, Mathieu A, et al . Physician’s Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study. J Rheumatol 2018;45:1256–62. 74 Bramer WM, De Jonge GB, Rethlefsen ML, et al . A systematic approach to searching: an efficient and complete method to develop literature searches. jmla 2018;106:531–41. 75 Harris PA, Taylor R, Thielke R, et al . Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. 76 Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med 2000;19:3127–31. 77 Guyatt GH, Thorlund K, Oxman AD, et al . GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles— continuous outcomes. J Clin Epidemiol 2013;66:173–83. 78 Hedges LV. Distribution Theory for Glass’s Estimator of Effect size and Related Estimators. Journal of Educational Statistics 1981;6:107–28. 79 Mustafa RA, Santesso N, Brozek J, et al . The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. J Clin Epidemiol 2013;66:736–42. 80 Hultcrantz M, Rind D, Akl EA, et al . The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol 2017;87:4–13. 81 Oka A, Sartor RB. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases. Dig Dis Sci 2020;65:757–88. 82 Baunwall SMD, Terveer EM, Dahlerup JF, et al . The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. The Lancet Regional Health - Europe 2021;9:100181. 83 Hansen MM, Rågård N, Andreasen PW, et al . Encapsulated donor faeces for faecal microbiota transplantation: the Glyprotect protocol. Therap Adv Gastroenterol 2024;17. 84 Bosch B, Hartikainen A, Ronkainen A, et al . Development of a Protocol for Anaerobic Preparation and Banking of Fecal Microbiota Transplantation Material: Evaluation of Bacterial Richness in the Cultivated Fraction. Microorganisms 2023;11:2901.
38 Aqaeinezhad Rudbane SM, Rahmdel S, Abdollahzadeh SM, et al . The efficacy of probiotic supplementation in rheumatoid arthritis: a meta-analysis of randomized, controlled trials. Inflammopharmacology 2018;26:67–76. 39 Lowe JR, Briggs AM, Whittle S, et al . A systematic review of the effects of probiotic administration in inflammatory arthritis. Complement Ther Clin Pract 2020;40:101207. 40 Sanchez P, Letarouilly J-G, Nguyen Y, et al . Efficacy of Probiotics in Rheumatoid Arthritis and Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients 2022;14:354. 41 Ross E, Abulaban K, Kessler E, et al . Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic review. Lupus (Los Angel ) 2022;31:864–79. 42 Wagenaar CA, van de Put M, Bisschops M, et al . The Effect of Dietary Interventions on Chronic Inflammatory Diseases in Relation to the Microbiome: A Systematic Review. Nutrients 2021;13:3208. 43 Chang A, Winquist NW, Wescott AB, et al . Systematic review of digital and non-digital non-pharmacological interventions that target quality of life and psychological outcomes in adults with systemic lupus erythematosus. Lupus (Los Angel ) 2021;30:1058–77. 44 Monti S, Delvino P, Riboli M, et al . The role of trimethoprim/ sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis. Rheumatology (Sunnyvale ) 2021;60:3553–64. 45 Nelson J, Sjöblom H, Gjertsson I, et al . Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials. Nutrients 2020;12:2991. 46 Islam MA, Khandker SS, Kotyla PJ, et al . Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review. Front Immunol 2020;11:1477. 47 Kazemi A, Soltani S, Ghorabi S, et al . Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials. Clin Nutr 2020;39:789–819. 48 Mirfeizi Z, Mahmoudi M, Faridzadeh A. Probiotics as a complementary treatment in systemic lupus erythematosus: A systematic review. Health Sci Rep 2023;6:e1640. 49 Turk MA, Liu Y, Pope JE. Non-pharmacological interventions in the treatment of rheumatoid arthritis: A systematic review and meta- analysis. Autoimmun Rev 2023;22:103323. 50 Wu T, Li Y, Wu Y, et al . Effects of Microecological Regulators on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Nutrients 2023;15:1102. 51 Zeng L, Deng Y, Yang K, et al . Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis. Front Immunol 2022;13:944387. 52 Zeng L, Deng Y, He Q, et al . Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: A systematic review and meta-analysis of 34 randomized controlled trials. Front Immunol 2022;13:961325. 53 Ranjbar M, Naeini F, Rostamian A, et al . Effects of probiotics supplementation in gastrointestinal complications and quality of life of patients with systemic sclerosis: A systematic review. Heliyon 2024;10:e36230. 54 Zeng L, Yang K, He Q, et al . Efficacy and safety of gut microbiota- based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials. BMC Med 2024;22:110. 55 Chandler J, Cumpston M, Li T, et al . Cochrane Handbook for Systematic Reviews of Interventions Version . 6. . .2019:.5. 56 Cumpston M, Li T, Page MJ, et al . Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 2019;10:Ed000142. 57 Higgins JPT TJ, Chandler J, CumpstonM, eds. Cochrane Handbook for Systematic Reviews of Interventions .2019. Available: https:// onlinelibrary.wiley.com/doi/book/10.1002/9781119536604 58 Shamseer L, Moher D, Clarke M, et al . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;350:g7647. 59 Liberati A, Altman DG, Tetzlaff J, et al . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1–34. 60 Hill C, Guarner F, Reid G, et al . The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506–14.
11
Kragsnaes MS, et al . BMJ Open 2025; 15 :e101593. doi:10.1136/bmjopen-2025-101593
Powered by FlippingBook